28 November 2018: The Federal Ministers give a final decision (positive) for this trial
Trial reference:
A first-time-in human, Phase I, study to evaluate the reactogenicity, safety immunogenicity and efficacy of HBV viral vectored vaccines given in a prime-boost schedule in chronic Hepatitis B patients